The main question arising is that the presence of CD8+ cells in the tumor microenvironment is not a prerequisite for response to immunotherapy, as the CD8+ cells could be anergic and/or exhausted and not capable of promoting tumor-mediated killing. The gene discussed is CD8A; the disease is neoplasm.